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314 converted the bulk of the Xbp1 mRNA pool to the spliced form by 4 h post-treatment, even 315 though IRE1α accumulation was still blocked. Consistent with our previous observations total 316 ATF6 levels increased during the lytic cycle, and protein species with different electrophoretic 317 mobilities could be detected by the ATF6 antiserum. Extended Tg or Tm treatments caused 318 accumulation of the ATF6(N) transcription factor exclusively in the lytic cells. Taken together, 319 these observations confirm that XBP1s and ATF4 transcription factors fail to accumulate in the 320 KSHV lytic cycle despite robust activation of UPR sensors after chemically-induced ER stress. 321 322 XBP1s target genes are not transactivated by XBP1s during lytic replication 323 To better understand the kinetics of IRE1 activity during KSHV lytic replication we reactivated 324 TREx BCBL1-RTA cells from latency using dox and monitored IRE1 activity over a 24 h time 325 course. Spliced XBP1 mRNA and XBP1s protein were detected by 6 h post-dox addition, 326 concomitant with a modest increase in IRE1 phosphorylation as determined by retarded IRE1 327 mobility on an immunoblot probed with an anti-IRE1α antibody (Fig. 4A ). This induction of 328 Xbp1 splicing corresponds with the increase in the early viral protein ORF45. By 18 hours post 329 dox addition, which coincides with the beginning of viral genome replication in this model [58] , 330 IRE1 phosphorylation, Xbp1 splicing and XBP1s accumulation had peaked, with almost 40% of 331 Xbp1 mRNA in the spliced isoform; however, these phenotypes were surpassed by the Tg 332 positive control ( Fig. 4A and B) . We wanted to test if the low levels of XBP1s that we observe 333 during lytic replication would be sufficient to induce synthesis of XBP1s target genes. We 334 harvested RNA from latent and lytic (24 h post dox addition) TREx BCBL1-RTA cells treated 335 with either Tg or Tm or left untreated and performed semiquantitative RT-PCR analysis. As 336 previously observed, Xbp1 mRNA was efficiently spliced following Tg or Tm treatment, both in 337 latent and lytic samples, while moderate splicing was observed in the mock-treated lytic samples 338 ( Fig. 4C ). RT-qPCR was performed to measure relative levels of canonical XBP1s target genes 339 EDEM1 and ERdj4 [73] ( Fig. 4D ). Indeed, Tg and Tm treatments caused dramatic accumulation 340 of EDEM1 and ERdj4 transcripts in latently infected cells, whereas these transcripts remained at 341 low levels in lytic cells treated with Tg, Tm or mock-treated. Thus, low expression of XBP1s 342 during lytic replication did not induce synthesis of canonical XBP1s target gene products 343 involved in ER stress mitigation. 344 345 UPR sensor activation supports efficient KSHV replication 346 We next used a combination of genetic and pharmacologic approaches to inhibit each of the UPR 347 sensor proteins and measure their impact on KSHV lytic replication. To investigate the role of 348 ATF6, we silenced ATF6 expression in TRex BCBL-RTA cells with shRNAs ( Fig. 5A ) and 349 collected cell supernatants from ATF6-silenced or control cells at 48 h post-dox addition. Cell 350 supernatants were processed to measure relative levels of released capsid-protected viral 351 genomes by qPCR. ATF6 knockdown reduced virus titre by ~50% compared to cells transduced 352 with non-targeting shRNA ( Fig. 5B ). To determine whether activation of PERK or downstream 353 engagement of the ISR are important for viral replication TREx BCBL1-RTA cells were treated 354 with the selective PERK inhibitor GSK2606414 (PERKi) or the ISR inhibitor ISRIB, a small 355 molecule that blocks phospho-eIF2-mediated inhibition of translation by maintaining active 356 eIF2B [74, 75] . PERKi and ISRIB each inhibited viral particle release by ~50% ( Fig. 5C ).
357
To determine if IRE1 RNase activity is required for efficient viral replication TREx BCBL1-358 RTA cells were treated with the IRE1 inhibitor 4μ8c [76], which inhibited virus release in a 359 dose-dependent manner (Fig. 6A ). We corroborated these findings in the dox-inducible 360 iSLK.219 cell model that produces KSHV virions bearing GFP transgenes [77]; cells were 361 treated with 4μ8c at the time of dox addition and cell supernatants were harvested 96 hours later, 362 serially diluted, and titered on naive monolayers of 293A cells by flow cytometry. As in the 363 TREx BCBL1-RTA cell model, higher doses of 4μ8c inhibited virion production from iSLK.219 364 cells, with statistically significant inhibition achieved at the 25 M dose ( Fig. 6B ). To confirm 365 these observations, we inhibited IRE1α expression in iSLK.219 cells via RNA silencing. Cells 366 transduced with IRE1α-targeting shRNAs or non-targeting controls were treated with dox for 96 367 hours, and cell supernatants were once again collected to titer GFP-expressing KSHV virions by 368 flow cytometry. iSLK.219 cells bearing IRE1α shRNAs inhibited release of infectious virions by 369 more than two-fold ( Fig. 6C, 6D ). Taken together, these data suggest that all three sensors of the 370 UPR are important for robust virus replication. 371 372 Ectopic XBP1s expression inhibits release of infectious KSHV virions in a dose-dependent 373 manner 374 Our studies to this point suggested that efficient lytic replication depends on activation of all 375 three UPR sensor proteins, but the cell fails to produce UPR transcription factors and 376 downstream transcriptional responses required to mitigate ER stress. This suggests that KSHV 377 may re-dedicate the UPR sensors for a new purpose other than to resolve ER stress, and that 378 sustained ER stress may have little impact on viral replication. We also found it puzzling that 379 IRE1 RNase activity was required for efficient lytic replication but XBP1s could not 380 transactivate XBP1s-target genes, including RTA. Furthermore, XBP1s protein levels were 381 reduced following treatment with chemical inducers of ER stress during the lytic cycle despite 382 clear IRE1 activation and efficient Xbp1 mRNA splicing. For these reasons, we hypothesized 383 that XBP1s accumulation may negatively impact KSHV replication. To complement the XBP1s 384 deficiency in the KSHV lytic cycle we overexpressed XBP1s using dox-inducible lentiviral 385 vectors. We engineered myc-tagged XBP1s to be weakly expressed under the control of a single 386 tet operator (TetO) element, or strongly expressed under the control of seven tandem TetO 387 elements. We transduced iSLK.219 cells with these constructs or an empty vector control, and 388 selected stable cells with blasticidin antibiotic. With the addition of dox, XBP1s and RTA were 389 concurrently expressed from dox-inducible promoters. To demonstrate that the ectopic XBP1s 390 was functional we measured mRNA levels of the XBP1s-target gene ERdj4 and observed that it 391 is upregulated in cells expressing XBP1s from the 7xTetO compared to empty vector control and 392 peaks at 24 hours post dox addition ( Fig.7A ). These cells also displayed higher levels of mRNA 393 and protein for RTA and the RTA target gene ORF45 by 24 hours post-dox treatment; and by 48 394 hours, mRNA encoding the late viral protein K8.1 was markedly increased compared to controls 395 ( Fig. 7A and B ), suggesting accelerated viral genome replication. Indeed, intracellular levels of 396 viral genomes at 96 h post-dox were two-fold higher in XBP1s-overexpressing cells compared to 397 empty vector ( Fig. 7C ). We harvested cell supernatants at 48, 72, and 96 hours post dox and 398 measured virion titer as previously described. Surprisingly, despite accelerated viral gene 399 expression and genome replication in XBP1s-overexpressing cells, there was a dramatic, dose-400 dependent reduction in virion production by 72 and 96 hours post-dox compared to empty vector 401 control ( Fig. 7D ). There was also a corresponding 20-fold decrease in release of viral particles by 402 XBP1s-overexpressing cells compared to controls, as measured by qPCR for capsid-protected 403 viral genomic DNA ( Fig. 7E ). Thus, while ectopic XBP1s expression promotes KSHV lytic gene 404 expression and genome replication, it prevents efficient release of infectious progeny.
451
Discussion 452 XBP1s-mediated transactivation of the RTA promoter causes reactivation from latency, but little 453 is known about how ER stress and the UPR affect the lytic replication cycle that follows. Here 454 we report that activation of all three UPR sensors (PERK, IRE1, ATF6) is required for efficient 455 KSHV lytic replication, because genetic or pharmacologic inhibition of each UPR sensor 456 diminishes virion production. Despite strong UPR sensor activation during KSHV lytic 457 replication, downstream UPR transcriptional responses were restricted. Paradoxically we found 458 that although XBP1s can trigger reactivation by upregulating RTA, forced expression of XBP1s 459 blocks virion production, despite accelerating lytic gene expression and genome replication. 460 These findings suggest that XBP1s has antiviral properties that KSHV must circumvent during 461 the lytic cycle to ensure efficient viral replication. This provides a tidy rationale for viral 462 blockade of XBP1s production during the lytic cycle, but significantly more work will be 463 required to elucidate precise mechanisms of viral activation of UPR sensors and inhibition of 464 downstream UPR transcriptional responses. 465
All three UPR sensors are activated concurrently during the lytic cycle, which suggests that 466 they may be responding to canonical protein misfolding events in the ER. Such misfolding could 467 be the result of viral glycoprotein biogenesis, but we think this scenario is unlikely because UPR 468 sensor activation in the BCBL-1 and iSLK.219 cell models precedes viral genome replication 469 and bulk synthesis of most structural viral glycoproteins. We favour an alternative hypothesis 470 that lytic replication disrupts ER chaperone function in some way, perhaps through the direct 471 action of viral proteins or indirect activation of signal transduction pathways. It seems 472 counterintuitive that an enveloped virus would actively trigger ER stress, but we speculate that 473 UPR activation in the earliest stages of lytic replication could help prime the ER for the 474 impending increase in viral glycoprotein synthesis. A more comprehensive accounting of 475 changes in gene expression during early lytic replication is required to determine whether there is 476 indeed an activation of an adaptive UPR to prepare the cell for late gene expression. 769 RNA was isolated from TREx BCBL1-RTA cells with the RNeasy Plus Kit (Qiagen) and 500 ng 770 total RNA was reverse transcribed with qScript cDNA SuperMix (Quanta) according to 771 manufacturers' protocols. Based on the Ron Lab protocol 772 (http://ron.cimr.cam.ac.uk/protocols/XBP-1.splicing.06.03.15.pdf) and minor modifications, a 773 473 bp PCR product overlapping the IRE1 splice site was amplified with XBP1 Fwd primer (5'-774 AAACAGAGTAGCAGCTCAGACTGC-3') and XBP1 Rev primer (5'-775 TCCTTCTGGGTAGACCTCTGGGAG-3'). The amplified PCR product was digested overnight 776 with 40 units of High Fidelity PstI (New England Biolabs) to cleave unspliced XBP1 cDNA. The 777 PCR products were resolved on a 2.5% agarose gel made with 1x TAE (Tris-acetate-EDTA) 778 buffer and stained with SYBR Safe (ThermoFisher) and visualized on a ChemiDoc Imaging 779 Station (Bio-Rad). Percent Xbp1 mRNA splicing was calculated by densitometry analysis with 780 Image Lab software ver. 6.0.0 (Bio-Rad) and calculated using the following formula: 781 % = . * + + + + * 815 modifications: 10 μg of salmon sperm DNA (Invitrogen) and 1 ng of luciferase plasmid 816 pGL4.26[luc2/minP/Hygro] (Promega) were added to the lysis buffer. RT-PCR was performed 817 as described previously with primers specific to KSHV ORF26 (as listed previously) and luc2 (F: 818 5'-TTCGGCAACCAGATCATCCC-3'; R: 5'-TGCGCAAGAATAGCTCCTCC-3'). Changes in 819 virus titre was calculated by the ∆∆Cq method and normalized to luc2 820 821 rKSHV.219 infection and titering 822 Virus-containing supernatant was harvested from iSLK.219 cells at the indicated times by 823 pelleting cellular debris at 3300 x g for 5 minutes and then stored at -80˚C until ready to titer the 824 virus. 1x10 5 293A cells/well were seeded in 12-well plates to obtain a confluent monolayer two 825 days later. The thawed viral inoculum was briefly vortexed and centrifuged again at 3300 x g for 826 5 minutes. Two-fold serial dilutions of viral supernatants were applied to the monolayer 827 containing 4 μg/ml polybrene and 25 mM HEPES (Gibco) and centrifuged at 800 x g for 2 hours 828 at 30˚C. The total cell count per well was also determined from an uninfected well. Fresh media 829 was applied immediately after spinoculation. 20-24 hours post infection, two dilutions that 830 resulted in less than 30% GFP-positive cells (the linear range for infection [data not shown]) 831 were trypsinized, washed once with PBS and fixed with 1% paraformaldehyde in PBS. GFP-832 positivity was measured on either FACSCalibur or FACSCanto cytometers (BD) by gating on 833 FSC/SSC and counting 10000-15000 "live" events. Gating and % GFP positive events was 834 determined with FCS Express 6 Flow Cytometry Software (ver.6.0; De Novo). Virus titre was 835 calculated as IU/mL with the following formula: 836 837
( / ) = % * * * 838 839 The two dilution series were averaged for the final titre value. 840 841 Statistical analysis 842 Prism7 (GraphPad) was used for generating graphs and performing statistical analysis. Unpaired 843 Student's t-tests were used to determine significance between two groups. One-way or two-way 844 ANOVA was used to compare multiple samples or between grouped samples respectively, and 845 an appropriate post-hoc test was done to determine differences between groups. p-values <0.05 846 were considered significant and denoted as the following: <0.05 (*), <0.01 (**), <0.001 (***), 847 <0.0001 (****) 848 849
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